CTCAWPWM: Comparison of Turkish Children's Actual Weights With Which Predicted Weights by Estimation Methods
Sponsor
Bozok University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06152770
Collaborator
(none)
2,600
9
Study Details
Study Description
Brief Summary
The goal of this observational study is to compare body weigth with the prediceted weigth values abtracted by weigth estimation methods in Turkish Children.
The main question it aims to answer is: to evaluate the suitability of APLS, Luscombe & Owens, Best Guess, Nelson Formula and Broselow Band methods in estimating actual measurements in patients coming to the surgery outpatient clinic of our hospital
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational [Patient Registry]
Anticipated Enrollment
:
2600 participants
Observational Model:
Case-Only
Time Perspective:
Other
Official Title:
Comparison of Turkish Children's Actual Weights With Predicted Weights Values by APLS, Luscombe and Owens, Best Guess, Nelson Formulas and Broselow Band Methods
Anticipated Study Start Date
:
Dec 1, 2023
Anticipated Primary Completion Date
:
Aug 1, 2024
Anticipated Study Completion Date
:
Sep 1, 2024
Outcome Measures
Primary Outcome Measures
- Comparison of actual weigth with predicted weigth [one year]
Eligibility Criteria
Criteria
Ages Eligible for Study:
0 Days
to 18 Years
Sexes Eligible for Study:
All
Inclusion Criteria:admitted to the pediatric surgery clinic 0-18 years old patients will be included
Exclusion Criteria:Those who have a disease that will cause severe developmental growth retardation will be excluded
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Bozok University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Yesim Senayli,
assistant professor,
Bozok University
ClinicalTrials.gov Identifier:
NCT06152770
Other Study ID Numbers:
- YSenayli
First Posted:
Dec 1, 2023
Last Update Posted:
Dec 1, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: